Investor · Dallas, TX
Kevin S. Lavelle
Open Kevin in the network graph →Capital
$1.4M
across filings
Active
Jul 2021
to Feb 2023
Most-connected co-filers (48)
Arena Investors, Lp · New York, NY2 sharedPaul Sealy · New York, NY2 sharedLawrence Cutler · New York, NY2 sharedDaniel Zwirn · New York, NY2 sharedDeborah Jones · Raleigh, NC2 sharedMatthew Hobbs · Raleigh, NC2 sharedMilind Deshpande · Waltham, MA2 sharedAngus Burt · Edinburgh, United Kingdom2 sharedPatrick E. Vink · Cambridge, MA2 sharedCynthia C. Smith · Cambridge, MA2 sharedSatyavrat E. Shukla · Cambridge, MA2 sharedTamara C. Joseph · Cambridge, MA2 sharedScott C. Jackson · Cambridge, MA2 sharedTimothy C. Keutzer · Cambridge, MA2 sharedFrank E. Thomas · Cambridge, MA2 sharedAnkit J. Mahadevia · CAMBRIDGE, MA2 sharedPhilippe Cousteau · Los Angeles, CA2 sharedLeland `. Ulrich · Grandview, TX2 sharedBob L. Dake · West Palm Beach, FL2 sharedJordan L. Fried · West Palm Beach, FL2 sharedLex Ferenda Litigation Funding GP LLC · Rye Brook, NY2 sharedLex Ferenda Litigation Funding LLC · Rye Brook, NY2 sharedJohn Wires · Shawnee, KS2 sharedAndreas Muehler · New York, NY2 shared Recent filings (8)
Project Monitor, Inc.Apr 2024 · 1 co-filer$3.9MProject Monitor, Inc.Apr 2024 · 1 co-filer$3.9MProject Monitor, Inc.Dec 2023 · 1 co-filer$3.0MProject Monitor, Inc.Dec 2023 · 1 co-filer$3.0MProject Monitor, Inc.Feb 2023 · 2 co-filers$1.0MSpero Therapeutics, Inc.Nov 2022 · 32 co-filers$9.0MProject Monitor, Inc.Oct 2022 · 2 co-filers$1.1MArena Special Opportunities Partners II, LPJul 2021 · 14 co-filersArena Special Opportunities Partners (Feeder) II, LPJul 2021 · 14 co-filersSpero Therapeutics, Inc.Jul 2021 · 34 co-filers$40.0M Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Kevin in the interactive graph →